Hepatocellular Carcinoma Treatment and Prognosis

BACKGROUND: Cabozantinib inhibits tyrosine kinases, including vascular endothelial growth factor receptors 1, 2, and 3, MET, and AXL, which are implicated in the progression of hepatocellular carcinoma and the development of resistance to sorafenib, the standard initial treatment for advanced disease. This randomized,…

• İRFAN ÇİÇİN

Özet henüz yok.

• YUSUF YILMAZ

BACKGROUND: The burden of non-alcoholic fatty liver disease (NAFLD) is increasing globally, and a major priority is to identify patients with non-alcoholic steatohepatitis (NASH) who are at greater risk of progression to cirrhosis, and who will be candidates for clinical trials and emerging new pharmacotherapies. We a…

• YUSUF YILMAZ

Özet henüz yok.

• TUNCAY GÖKSEL

Six existing minimally invasive techniques for the treatment of primary and secondary malignant hepatic tumors--radio-frequency ablation, microwave ablation, laser ablation, cryoablation, ethanol ablation, and chemoembolization--are reviewed and debated by noted authorities from six institutions from around the world.…

• ÖKKEŞ İBRAHİM KARAHAN

Özet henüz yok.

• ONUR KESKİN

Özet henüz yok.

• RAMAZAN İDİLMAN

Özet henüz yok.

• RAMAZAN İDİLMAN

Özet henüz yok.

• RAMAZAN İDİLMAN

OBJECTIVE: Liver biopsy is still needed for fibrosis staging in many patients with non-alcoholic fatty liver disease. The aims of this study were to evaluate the individual diagnostic performance of liver stiffness measurement by vibration controlled transient elastography (LSM-VCTE), Fibrosis-4 Index (FIB-4) and NAFL…

• YUSUF YILMAZ

Özet henüz yok.

• ŞUAYİB YALÇIN

Özet henüz yok.